RASSF1 and differentiated thyroid carcinoma: For example, in one study [121], high RASSF1 methylation of the CpG island in the RASSF1A promoter was found in all patients with PDTC and in 78% of ATC cases, but it was relatively low in differentiated thyroid cancer [121].